MENU
Advertisement
With commentary from Michael P. Thompson, PhD
Reprints
View Supplement
COAPT 5-Year Data Demonstrate Benefits of Mitral TEER, Reveal Need to Address Underlying LV Dysfunction
With commentary from Gregg Stone, MD
left-arrow Created with Sketch. Previous Article
Renal Denervation: Where We Stand After the FDA Panels
With Ajay J. Kirtane, MD, SM; Eric A. Secemsky, MD, MSc, RPVI, FACC, FSCAI, FSVM; and Taisei Kobayashi, MD
Next Article right-arrow Created with Sketch.
Modern Clinical Trials Spotlight
Insights on current trial designs, inclusivity, and next steps.
View Issue
CT-Guided PCI: Toward Precision in Case Triage and Procedural Planning
By Yader Sandoval, MD, and Emmanouil S. Brilakis, MD, PhD
The Role of Cardiac CT for Successful TAVR Planning
By Harika Sai Dabbara, MD, and Lauren Sharan Ranard, MD, MS
enVast™: Engineered for Coronary Thrombectomy
By Marco Valgimigli, MD, PhD
An Interview With Nidhi Madan, MD, MPH
Controversies in Renal Denervation
With Joseph E. Ebinger, MD, MS, FACC; Maria Carolina Delgado-Lelievre, MD; Atul Chugh, MD, FACC, RPVI; Brian C. Bigelow, MD, FACC, FSCAI, FSVM; Eric A. Secemsky, MD, MSc, RPVI, FACC, FAHA, FSCAI, FSVM; and Joachim Weil, MD
